Cargando…
Engineering dendritic cell vaccines to improve cancer immunotherapy
At the interface between the innate and adaptive immune system, dendritic cells (DCs) play key roles in tumour immunity and hold a hitherto unrealized potential for cancer immunotherapy. Here we review the role of distinct DC subsets in the tumour microenvironment, with special emphasis on conventio...
Autores principales: | Perez, Caleb R., De Palma, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881351/ https://www.ncbi.nlm.nih.gov/pubmed/31776331 http://dx.doi.org/10.1038/s41467-019-13368-y |
Ejemplares similares
-
Liposomal Dendritic Cell Vaccine in Breast Cancer
Immunotherapy
por: Pan, Hong, et al.
Publicado: (2021) -
Research progress on dendritic cell vaccines in cancer immunotherapy
por: Yu, Jifeng, et al.
Publicado: (2022) -
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Is there a role for immunotherapy in HER2-positive breast cancer?
por: Holgado, Esther, et al.
Publicado: (2018) -
NK cell-based immunotherapy for treating cancer: will it be promising?
por: Cho, Duck, et al.
Publicado: (2011)